Mesenchymal stem cell (MSC) transplantation, as an alternative strategy to orthotopic liver
transplantation, has been evaluated for treating end-stage liver disease. Although the …

The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver
fibrosis is predominantly based on their immunosuppressive properties, and their ability to …

Mesenchymal stem cells (MSCs) are multi-potent adult stem cells harboring multi-lineage
differentiation potential and immunosuppressive properties that make MSCs an ideal …

Retinoid-storing hepatic stellate cells (HSCs) have recently been described as a liver-
resident mesenchymal stem cell (MSC) population; however, it is not clear whether these …

Introduction• Mesenchymal stem cells and its characteristics• Experimental/preclinical MSC‐
based studies–MSC transplantation–Genetically modified MSC‐based therapy–MSC‐based …

Background Mesenchymal progenitor cells (MPCs) have been isolated from a variety of
connective tissues, and are commonly called “mesenchymal stem cells”(MSCs). A stem cell …

Mesenchymal stem cells (MSCs) possess a set of several fairly unique properties which
make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles …

Progressive liver fibrosis is a major health issue for which no effective treatment is available,
leading to cirrhosis and orthotopic liver transplantation. However, organ shortage is a reality …

Background There is increasing interest in the therapeutic potential of human mesenchymal
stem cells (hMSCs), especially in diseases such as acute hepatic failure (AHF) that are …

Neurodegenerative disease is a kind of chronic, progressive nervous system disease
characterized by neuron degeneration or apoptosis. Current treatments cannot prevent the …